Allergy Therapeutics (AGY)

Company name:Allergy Thera.
EPIC:AGYTrading Currency:GBX
Market Sector:AIMISIN:GB00B02LCQ05
Market Segment:AIMShare Type:DE
WWW Address:Description:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 20.00 mages.advfn.com/imagesnew/2/us/up 0.25 [1.27] 19.50 20.50 19.75 20.00 19.75 103,746
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 118.69 593.44 0.25 -2.29 - - - 32.50 - 17.38

Allergy Therapeutics Key Figures

(at previous day's close)
Market Cap.118.69m
Shares In Issue593.44m
Prev. Close19.75
PE Ratio- 
Dividend Yield-%
EPS - basic-2.29p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.99p
Return On Equity (ROE)-43.11%
Operating Margin-24.87%
PEG Factor- 
EPS Growth Rate-11,550.00%
Dividends PS Growth Rate-%
Net Debt2.95m
Gross Gearing46.50%
Quick Assets29.92m
Net Working Capital25.09m
Intangibles / Fixed Assets28.09%
Turnover PS8.17p
Pre-Tax Profit PS-2.03p
Retained Profit PS-2.20p
Cash PS3.94p
Net Cash PS1.83p
Net Tangible Asset Value PS *4.21p
Net Asset Value PS5.11p
Spread1.00 (4.88%) 

Allergy Therapeutics Balance Sheet

LSE:AGY:Liabilities+EQLSE:AGY:Assets

Share Price Performance

Sample Period HighLow
1 week20.7519.75
4 weeks21.6319.75
12 weeks28.3817.38
1 year32.5017.38

Share Price Chart (5 years)

Allergy Therapeutics Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week20.75-0.75-3.6120.000.1020.05
4 weeks20.63-0.63-3.0320.890.1621.15
12 weeks18.381.638.8421.230.4920.90
26 weeks24.75-4.75-19.1920.500.3320.36
1 year32.50-12.50-38.4623.590.2121.81
3 years8.2511.75142.4222.240.2421.10
5 years10.639.3888.2417.430.3414.65

Allergy Therapeutics Key Management Ratios

Allergy Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 2.21 
Tobin's Q Ratio (excl. intangibles)2.45 
Dividend Yield-%
Market-to-Book Ratio3.91 
Price-to-Pre-Tax Profit PS-9.84 
Price-to-Retained Profit PS-9.08 
Price-to-Cash Flow PS-10.03 
Price-to-Sales PS2.45 
Price-to-Net Tangible Asset Value PS4.75 
Price-to-Cash PS5.07 
Net Working Capital PS4.23 
Price Pct to Working Capital PS4.73%
Earnings Yield-%
Average PE323.62 
Years in average4 
PE to PE average-%

Allergy Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio31.33%
Debt-to-Equity Ratio0.46 
Debt-to-Equity Ratio (excl. Intgbl)0.55 
Debt-to-Equity Market Value0.12 
Net Gearing5.20%
Net Gearing (excl. Intangibles)5.75%
Gross Gearing46.50%
Gross Gearing (excl. Intangibles)51.35%
Gearing Under 1 Year22.09%
Gearing Under 1 Year (excl. Intgbl)24.39%
Assets/Equity1.87 
Cash/Equity77.19 
(Liquidity Ratios)
Net Working Capital to Total Assets44.27%
Current Ratio3.00 
Quick Ratio (Acid Test)2.39 
Liquidity Ratio1.87 
Cash & Equiv/Current Assets62.23%
(Solvency Ratios)
Enterprise Value109.12m
CFO/Sales-0.24 
CFO/Attributable Profit- 
CFO/Assets-0.21 
CFO/Debt-0.45 
Total Debt/Equity Market Value0.22 
Total Debt/Sales0.54 
Total Debt/Pre-Tax Profit-2.18 
Total Debt26.36m
Total Debt/Net Current Assets1.05%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-22.45%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)
0.25410.2914
Alpha (60-Mnth)Alpha (36-Mnth)
0.02700.0495

Allergy Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-27.32%
Return On Assets (ROA)-24.35%
Net Profit Margin-26.95%
Assets Turnover0.90 
Return On Equity (ROE)-43.11%
Return On Investment (ROI)-29.90%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-26.95%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.50 
Fixed Assets Turnover2.64 
Current Assets Turnover1.37 
Net Working Capital Turnover 
Inventory Turnover6.72 
(Other Operating Ratios)
Total Assets-to-Sales1.11 
Debtors-to-Sales11.93%
Debt Collection Period43.54Days

Allergy Therapeutics Dividends

Sorry No Data Available

Allergy Therapeutics Fundamentals

 30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)30 Jun 2016 (GBP)
turnover39.28100.00%41.96100.00%43.23100.00%48.51100.00%m
pre tax profit0.431.10%1.082.58%0.651.51%-12.06-24.87%m
attributable profit0.541.36%0.741.77%0.110.25%-13.07-26.95%m
retained profit0.541.36%0.741.77%0.110.25%-13.07-26.95%m
eps - basic0.13 0.16 0.02 -2.29 
eps - diluted0.13 0.16 0.02 -2.29 
dividends per share- - - - 

Allergy Therapeutics Balance Sheet

 30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)30 Jun 2016 (GBP)
LSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:Assets
 30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)30 Jun 2016 (GBP)
ASSETS
fixed assets fixed assets7.3425.33%7.0324.76%8.7517.26%9.6717.06%m
intangibles intangibles3.9113.50%3.7713.28%5.009.86%5.369.45%m
fixed investments fixed investments3.0610.57%3.5612.53%3.947.78%4.057.14%m
current assets - other current assets - other--%--%--%--%m
stocks stocks6.0120.76%6.4722.78%6.7513.31%7.6913.57%m
debtors debtors7.3925.50%5.5419.52%5.069.98%6.5111.49%m
cash & securities cash & securities1.264.34%2.037.14%21.2041.81%23.4141.30%m
TOTAL28.96100%28.40100%50.70100%56.68100%m
LIABILITIES
creditors - short creditors - short7.6226.31%6.4722.80%7.4214.64%12.5222.09%m
creditors - long creditors - long6.6723.04%6.8524.12%8.8117.38%13.8424.41%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL14.2949.35%13.3246.92%16.2332.01%26.3646.50%m
EQUITY
ord cap, reserves ord cap, reserves14.6750.65%15.0853.08%34.4767.99%30.3253.50%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL14.6750.65%15.0853.08%34.4767.99%30.3253.50%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Allergy Therapeutics Cash Flow Statement

30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)30 Jun 2016 (GBP)
Operating CF2.432.172.01-11.84m
Pre-Financing CF1.281.04-0.66-13.33m
Retained CF1.421.0419.42-0.79m

Allergy Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MMF)Broker/DealerCODECODCGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20161211 02:15:34